We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
-13.89%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$4.5B
AUM Growth
-$744M
(-14%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
3.51%
Top 10 Holdings %
Top 10 Hldgs %
18.83%
Holding
605
New
48
Increased
192
Reduced
136
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$39.6M |
| 2 |
HES
Hess
HES
|
+$34.3M |
| 3 |
Pfizer
PFE
|
+$14.5M |
| 4 |
XYZ
Block Inc
XYZ
|
+$12.3M |
| 5 |
Coca-Cola
KO
|
+$12.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$31.4M |
| 2 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$19.3M |
| 3 |
VMW
VMware, Inc
VMW
|
+$15.1M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$15.1M |
| 5 |
Cisco
CSCO
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.9% |
| 2 | Healthcare | 19.98% |
| 3 | Consumer Discretionary | 10.77% |
| 4 | Financials | 9.62% |
| 5 | Industrials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Medpace
MEDP
$16.1B
| $1.27M | 0.03% |
8,450
| – | – |
|
|
FOLD
327
DELISTED
Amicus Therapeutics
FOLD
| $1.26M | 0.03% |
116,850
| – | – |
|
328
Allstate
ALL
$68B
| $1.25M | 0.03% |
10,000
-4,500
| -31% | -$590K |
|
329
Whirlpool
WHR
$2.43B
| $1.25M | 0.03% |
7,909
-821
| -9% | -$143K |
|
330
Intercontinental Exchange
ICE
$85.6B
| $1.25M | 0.03% |
13,082
+7,245
| +124% | +$775K |
|
331
Berkshire Hathaway Class A
BRK.A
$1.1T
| $1.23M | 0.03% |
3
| – | – |
|
332
Cadence Design Systems
CDNS
$93.6B
| $1.21M | 0.03% |
8,000
| – | – |
|
333
Gartner
IT
$10.1B
| $1.2M | 0.03% |
5,000
| – | – |
|
334
Q32 Bio
QTTB
$466M
| $1.18M | 0.03% |
33,194
| – | – |
|
335
Sun Life Financial
SLF
$46B
| $1.17M | 0.03% |
25,500
-6,300
| -20% | -$314K |
|
336
MetLife
MET
$61.9B
| $1.16M | 0.03% |
18,500
-2,800
| -13% | -$185K |
|
337
Intellia Therapeutics
NTLA
$1.49B
| $1.16M | 0.03% |
22,145
+5,800
| +35% | +$295K |
|
338
Shopify
SHOP
$152B
| $1.16M | 0.03% |
35,000
-40,000
| -53% | -$1.71M |
|
339
Paychex
PAYX
$41.6B
| $1.15M | 0.03% |
10,000
| – | – |
|
340
American International
AIG
$41.7B
| $1.15M | 0.03% |
+22,600
| New | +$1.31M |
|
341
Arrowhead Research
ARWR
$11.9B
| $1.15M | 0.03% |
33,200
| – | – |
|
342
United Parcel Service
UPS
$88.6B
| $1.12M | 0.02% |
6,191
+2,918
| +89% | +$532K |
|
|
PXD
343
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.12M | 0.02% |
+4,950
| New | +$1.26M |
|
344
Marathon Petroleum
MPC
$92.4B
| $1.12M | 0.02% |
+13,200
| New | +$1.23M |
|
345
Xenon Pharmaceuticals
XENE
$6.06B
| $1.08M | 0.02% |
35,000
| – | – |
|
346
Parker-Hannifin
PH
$123B
| $1.06M | 0.02% |
4,300
+1,600
| +59% | +$428K |
|
347
Idexx Laboratories
IDXX
$44.1B
| $1.05M | 0.02% |
2,950
+130
| +5% | +$53K |
|
348
GeoPark
GPRK
$633M
| $1.05M | 0.02% |
80,000
| – | – |
|
349
Ascendis Pharma A/S
ASND
$16B
| $1.05M | 0.02% |
11,100
| – | – |
|
350
Boston Scientific
BSX
$69.5B
| $1.01M | 0.02% |
+26,755
| New | +$1.09M |
|
Similar funds
AIM
TRSOTSOK
GC
CII
AAMU
NMIFOAC
WANY
Erste Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Erste Asset Management held 605 positions worth $4.5B, down 14% from $5.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Erste Asset Management deployed $158M of net new capital in Q2 2022, opening 48 new positions and adding to 192 existing holdings. Its largest new stake was East-West Bancorp: 145,208 shares worth $9.42M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $31.4M trimmed.
- Erste Asset Management's largest Q2 2022 buy was East-West Bancorp: 145,208 shares worth $9.42M.
- Erste Asset Management added most to Netflix in Q2 2022, an estimated $39.6M increase.
- Erste Asset Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $31.4M.
- Erste Asset Management fully exited Houghton Mifflin Harcourt Company in Q2 2022, selling an estimated $19.3M.
- Erste Asset Management's ten largest holdings make up 19% of its $4.5B portfolio in Q2 2022.
- Erste Asset Management opened 48 new positions and closed 31 in Q2 2022.
- Erste Asset Management's portfolio value fell 14% quarter-over-quarter to $4.5B.
Based on Erste Asset Management's 13F filing for Q2 2022, filed 26 Nov 2024.